2nd May 2012
Chromogenex: May’s MediWales Featured Member
Chromogenex Technologies Ltd
Our Prodcuts
Chromogenex develop and manufacture lasers and intense pulsed light (IPL) systems for the health, cosmetic and beauty market. Our key products are:
- iLipo: The latest in laser lipolysis, a body shaping, fat reduction device without the need for pain, needles or downtime
- i-Lipo Ultra: Effective treatment to enhance lymphatic drainage, improve blood circulation, promote skin cell renewal, improving the appearance of cellulite
- Phaser MPL: intense pulse light (ipl) for hair removal, skin rejuvenation and pigmentation
- Regenlite: a pulse dye laser for vascular, acne, skin pigmentation
- Fusion SLR: the latest in skin rejuvenation technology and incorporates three tehcnologies in one system. 1.Diamond exfoliation of the surface layer of the skin, 2.Infusion of topical Hyaluron gel using Acoustic Wave Technology, 3.Application of the Fusion Infra Red laser then activates the gel and delivers heat to the Dermis, the lower part of the skin structure. This in turn stimulates the production of collagen and elastin and tightens the skin for a lift effect
We have recently received FDA clearance in the US for our i-Lipo Laser for ‘Circumferential Reduction’ which is the first non-invasive skin contact system to receive such clearance.
About
Since 1985, Chromogenex Technologies LTD has been at the forefront of laser and light technology for aesthetic applications such as hair removal, skin rejuvenation, acne and vascular lesions. In 1994, the company developed and patented the world’s first Ruby laser for permanent hair reduction.
In 1998, we introduced the patented Nlite laser, the first laser to receive FDA clearance for wrinkle reduction and in 2000 we were the first company to receive FDA Approval for Inflammatory acne vulgaris, working with some of the world’s leading Dermatologists and Clinical Researchers.
Quality
Chromogenex Technologies Limited operates to a Medical Device Quality System that meets the European Medical Device Directive, United States FDA cGMP, and Canadian CMDCAS requirement, and accredited by the Notified Body SGS UK Ltd to BS EN ISO 13485:2003, CMDCAS, and BS EN 9001:2008. We have successfully distributed our devices throughout the World, meeting all product, system and regulatory requirements, and pride ourselves on the Quality of our Product Design , Assembly & Test , and after Sales Service.
Chromogenex has an established direct sales operations in the UK with a worldwide distribution network and a strong customer care, servicing and parts operation.
Web www.chromogenex.com
E-mail sales@chromogenex.com
Linked In http://www.linkedin.com/company/chromogenex-technologies-ltd
Tel. 01554 755444